ABSTRACT
Despite many years of study, abnormal chromosome number remains the most common and well-documented cause of miscarriage. Nonchromosomal factors that have been associated with miscarriage are many and include endocrine abnormalities, anatomic abnormalities, inherited and acquired thrombophilia, environmental exposures, immunologic factors, and others. This article attempts to provide a brief overview and critique of the frequently reported factors. In addition, we call attention to the fact that, to be most helpful, modern studies of miscarriage need to provide details about the sonographically determined gestational age and fetal anatomic development prior to or at the time of pregnancy loss. Such information will be critical in helping to sort out which miscarriage-associated factors are more relevant at which stage of fetal development.
KEYWORDS
Miscarriage - spontaneous abortion - recurrent abortion
REFERENCES
-
1
Nybo Andersen A M, Wohlfahrt J, Christens P, Olsen J, Melbye M.
Maternal age and fetal loss: population based register linkage study.
BMJ.
2000;
320
1708-1712
-
2
Hassold T, Abruzzo M, Adkins K et al..
Human aneuploidy: incidence, origin, and etiology.
Environ Mol Mutagen.
1996;
28
167-175
-
3 Kline J ZS. Spontaneous abortion (miscarriage). In: Bracken M Perinatal Epidemiology. New York, NY; Oxford University Press 1984: 23-51
-
4
Benadiva C A, Kligman I, Munne S.
Aneuploidy 16 in human embryos increases significantly with maternal age.
Fertil Steril.
1996;
66
248-255
-
5
Delhanty J D, Harper J C, Ao A, Handyside A H, Winston R M.
Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients.
Hum Genet.
1997;
99
755-760
-
6
Iwarsson E, Lundqvist M, Inzunza J et al..
A high degree of aneuploidy in frozen-thawed human preimplantation embryos.
Hum Genet.
1999;
104
376-382
-
7
Hassold T, Pettay D, Robinson A, Uchida I.
Molecular studies of parental origin and mosaicism in 45,X conceptuses.
Hum Genet.
1992;
89
647-652
-
8
Brancati F, Mingarelli R, Dallapiccola B.
Recurrent triploidy of maternal origin.
Eur J Hum Genet.
2003;
11
972-974
-
9
Warburton D, Dallaire L, Thangavelu M, Ross L, Levin B, Kline J.
Trisomy recurrence: a reconsideration based on North American data.
Am J Hum Genet.
2004;
75
376-385
-
10
Rubio C, Rodrigo L, Perez-Cano I et al..
FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome.
Reprod Biomed Online.
2005;
11
497-506
-
11
De Braekeleer M, Dao T N.
Cytogenetic studies in couples experiencing repeated pregnancy losses.
Hum Reprod.
1990;
5
519-528
-
12
Kleinhaus K, Perrin M, Friedlander Y, Paltiel O, Malaspina D, Harlap S.
Paternal age and spontaneous abortion.
Obstet Gynecol.
2006;
108
369-377
-
13
Slama R, Bouyer J, Windham G, Fenster L, Werwatz A, Swan S H.
Influence of paternal age on the risk of spontaneous abortion.
Am J Epidemiol.
2005;
161
816-823
-
14
Regan L, Braude P R, Trembath P L.
Influence of past reproductive performance on risk of spontaneous abortion.
BMJ.
1989;
299
541-545
-
15
Coutifaris C, Myers E R, Guzick D S et al..
Histological dating of timed endometrial biopsy tissue is not related to fertility status.
Fertil Steril.
2004;
82
1264-1272
-
16
Karamardian L M, Grimes D A.
Luteal phase deficiency: effect of treatment on pregnancy rates.
Am J Obstet Gynecol.
1992;
167
1391-1398
-
17
Bussen S, Steck T.
Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions.
Hum Reprod.
1995;
10
2938-2940
-
18
Stagnaro-Green A, Roman S H, Cobin R H, el-Harazy E, Alvarez-Marfany M, Davies T F.
Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies.
JAMA.
1990;
264
1422-1425
-
19
Rushworth F H, Backos M, Rai R, Chilcott I T, Baxter N, Regan L.
Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies.
Hum Reprod.
2000;
15
1637-1639
-
20
Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H.
Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications.
J Clin Endocrinol Metab.
2006;
91
2587-2591
-
21
Pearson D W, Kernaghan D, Lee R, Penney G C.
The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus.
BJOG.
2007;
114
104-107
-
22
Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A.
Reproductive impact of congenital Mullerian anomalies.
Hum Reprod.
1997;
12
2277-2281
-
23a
Salim R, Regan L, Woelfer B, Backos M, Jurkovic D.
A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage.
Hum Reprod.
2003;
18
162-166
-
23b
Pace S, Cipriano L, Pace G, Catania R, Montanino G.
Septate uterus: reproductive outcome after hysteroscopic metroplasty.
Clin Exp Obstet Gynecol.
2006;
33
110-112
-
24
Benson C B, Chow J S, Chang-Lee W, Hill III J A, Doubilet P M.
Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester.
J Clin Ultrasound.
2001;
29
261-264
-
25
Salvador E, Bienstock J, Blakemore K J, Pressman E.
Leiomyomata uteri, genetic amniocentesis, and the risk of second-trimester spontaneous abortion.
Am J Obstet Gynecol.
2002;
186
913-915
-
26
Bajekal N, Li T C.
Fibroids, infertility and pregnancy wastage.
Hum Reprod Update.
2000;
6
614-620
-
27
Lass A, Williams G, Abusheikha N, Brinsden P.
The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles.
J Assist Reprod Genet.
1999;
16
410-415
-
28
Cowchock S.
Autoantibodies and pregnancy wastage.
Am J Reprod Immunol.
1991;
26
38-41
-
29
Kutteh W H.
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
Am J Obstet Gynecol.
1996;
174
1584-1589
-
30
Rai R, Cohen H, Dave M, Regan L.
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
BMJ.
1997;
314
253-257
-
31
Rai R S.
Antiphospholipid syndrome and recurrent miscarriage.
J Postgrad Med.
2002;
48
3-4
-
32
Simpson J L.
Causes of fetal wastage.
Clin Obstet Gynecol.
2007;
50
10-30
-
33
Petri M, Golbus M, Anderson R, Whiting-O'Keefe Q, Corash L, Hellmann D.
Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women.
Arthritis Rheum.
1987;
30
601-606
-
34
Simpson J L, Carson S A, Chesney C et al..
Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception.
Fertil Steril.
1998;
69
814-820
-
35a
Robertson L, Wu O, Langhorne P et al..
Thrombophilia in pregnancy: a systematic review.
Br J Haematol.
2006;
132
171-196
-
35b
Empson M, Lassere M, Craig J, Scott J.
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
Cochrane Database System Review.
2005;
18
CD 002859
-
36
Brenner B.
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications—yes.
J Thromb Haemost.
2003;
1
2070-2072
-
37
Gris J C, Mares P.
The long and winding road ... towards LMWH for pregnancy loss.
J Thromb Haemost.
2005;
3
224-226
-
38
Lindqvist P G, Merlo J.
Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?.
J Thromb Haemost.
2005;
3
221-223
-
39
Middeldorp S.
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications—no.
J Thromb Haemost.
2003;
1
2073-2074
-
40
Middeldorp S.
Thrombophilia and pregnancy complications: cause or association?.
J Thromb Haemost.
2007;
5(Suppl 1)
276-282
-
41
Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J.
Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
J Thromb Haemost.
2005;
3
227-229
-
42
Gris J C, Mercier E, Quere I et al..
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Blood.
2004;
103
3695-3699
-
43
Vossen C Y, Preston F E, Conard J et al..
Hereditary thrombophilia and fetal loss: a prospective follow-up study.
J Thromb Haemost.
2004;
2
592-596
-
44
Lanasa M C, Hogge W A, Kubik C, Blancato J, Hoffman E P.
Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion.
Am J Hum Genet.
1999;
65
252-254
-
45
Pegoraro E, Whitaker J, Mowery-Rushton P, Surti U, Lanasa M, Hoffman E P.
Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28.
Am J Hum Genet.
1997;
61
160-170
-
46
Uehara S, Hashiyada M, Sato K, Sato Y, Fujimori K, Okamura K.
Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss.
Fertil Steril.
2001;
76
908-914
-
47
Hogge W A, Prosen T L, Lanasa M C, Huber H A, Reeves M F.
Recurrent spontaneous abortion and skewed X-inactivation: is there an association?.
Am J Obstet Gynecol.
2007;
196
e381-e388
-
48
Faulk W P.
Idiopathic spontaneous abortions.
Am J Reprod Immunol.
1983;
3
48-49
-
49
Faulk W P, McIntyre J A.
Immunological studies of human trophoblast: markers, subsets and functions.
Immunol Rev.
1983;
75
139-175
-
50
Beer A E, Quebbeman J F, Ayers J W, Haines R F.
Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans.
Am J Obstet Gynecol.
1981;
141
987-999
-
51
Taylor C G, Faulk W P, McIntyre J A.
Prevention of recurrent spontaneous abortions by leukocyte transfusions.
J R Soc Med.
1985;
78
623-627
-
52
Coulam C B, Coulam C H.
Update on immunotherapy for recurrent pregnancy loss.
Am J Reprod Immunol.
1992;
27
124-127
-
53
Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
Am J Reprod Immunol.
1994;
32
55-72
-
54
Ober C, Karrison T, Odem R R et al..
Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial.
Lancet.
1999;
354
365-369
-
55
Ober C, Hyslop T, Elias S, Weitkamp L R, Hauck W W.
Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study.
Hum Reprod.
1998;
13
33-38
-
56
Stray-Pedersen B, Eng J, Reikvam T M.
Uterine T-mycoplasma colonization in reproductive failure.
Am J Obstet Gynecol.
1978;
130
307-311
-
57
Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M.
Possible role of bacterial and viral infections in miscarriages.
Fertil Steril.
2004;
81
662-669
-
58
Simpson J L, Mills J L, Kim H et al..
Infectious processes: an infrequent cause of first trimester spontaneous abortions.
Hum Reprod.
1996;
11
668-672
-
59
Paukku M, Tulppala M, Puolakkainen M, Anttila T, Paavonen J.
Lack of association between serum antibodies to Chlamydia trachomatis and a history of recurrent pregnancy loss.
Fertil Steril.
1999;
72
427-430
-
60
Rae R, Smith I W, Liston W A, Kilpatrick D C.
Chlamydial serologic studies and recurrent spontaneous abortion.
Am J Obstet Gynecol.
1994;
170
782-785
-
61
Gardella J R, Hill III J A.
Environmental toxins associated with recurrent pregnancy loss.
Semin Reprod Med.
2000;
18
407-424
-
62
Hughes E G, Brennan B G.
Does cigarette smoking impair natural or assisted fecundity?.
Fertil Steril.
1996;
66
679-689
-
63
Armstrong B G, McDonald A D, Sloan M.
Cigarette, alcohol, and coffee consumption and spontaneous abortion.
Am J Public Health.
1992;
82
85-87
-
64
Himmelberger D U, Brown Jr B W, Cohen E N.
Cigarette smoking during pregnancy and the occurrence of spontaneous abortion and congenital abnormality.
Am J Epidemiol.
1978;
108
470-479
-
65
Kline J, Shrout P, Stein Z, Susser M, Warburton D.
Drinking during pregnancy and spontaneous abortion.
Lancet.
1980;
2
176-180
-
66
Streissguth A P, Martin D C, Martin J C, Barr H M.
The Seattle longitudinal prospective study on alcohol and pregnancy.
Neurobehav Toxicol Teratol.
1981;
3
223-233
-
67
Warburton D, Fraser F C.
Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit.
Am J Hum Genet.
1964;
16
1-25
-
68
Stevenson A C, Dudgeon M Y, Mc C H.
Observations on the results of pregnancies in women resident in Belfast. II. Abortions, hydatidiform moles and ectopic pregnancies.
Ann Hum Genet.
1959;
23
395-414
-
69
Naylor A F, Warburton D.
Sequential analysis of spontaneous abortion. II. Collaborative study data show that gravidity determines a very substantial rise in risk.
Fertil Steril.
1979;
31
282-286
-
70 Shapiro S, Levine H S, Abramovicz M. Factors associated with early and late fetal loss. Advances in Planned Parenthood VI Proc. VIII Annual Meeting of the AAPP, 45. Excerpta Medica International Congress Series Excerpta Medica 1970: 45-63
-
71
Awan A K.
Some biologic correlates of pregnancy wastage.
Am J Obstet Gynecol.
1974;
119
525-532
-
72
Boue J, Bou A, Lazar P.
Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions.
Teratology.
1975;
12
11-26
-
73
Lauristen J G.
Aetiology of spontaneous abortion: a cytogenetic and epidemiologic study of 288 cases.
Acta Obstet Gynecol Scand.
1976;
52(Suppl 1)
-
74
Harger J H, Archer D F, Marchese S G, Muracca-Clemens M, Garver K L.
Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies.
Obstet Gynecol.
1983;
62
574-581
-
75
FitzSimmons J, Jackson D, Wapner R, Jackson L.
Subsequent reproductive outcome in couples with repeated pregnancy loss.
Am J Med Genet.
1983;
16
583-587
Stephen BrownM.D.
Department of Obstetrics and Gynecology, University of Vermont
Burlington, VT 05401
Email: sabrown@uvm.edu
